Vaughan Nelson Investment Management L.P. Increases Stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Vaughan Nelson Investment Management L.P. increased its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 38.4% during the fourth quarter, Holdings Channel reports. The institutional investor owned 1,064,455 shares of the company’s stock after buying an additional 295,515 shares during the quarter. Vaughan Nelson Investment Management L.P.’s holdings in Acadia Healthcare were worth $42,206,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in ACHC. State Street Corp increased its position in shares of Acadia Healthcare by 3.5% in the 3rd quarter. State Street Corp now owns 2,819,911 shares of the company’s stock valued at $178,811,000 after purchasing an additional 95,613 shares during the last quarter. JPMorgan Chase & Co. increased its holdings in Acadia Healthcare by 17.0% in the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock valued at $198,258,000 after buying an additional 454,044 shares during the last quarter. SG Americas Securities LLC raised its stake in Acadia Healthcare by 713.3% in the fourth quarter. SG Americas Securities LLC now owns 110,866 shares of the company’s stock valued at $4,396,000 after buying an additional 97,235 shares in the last quarter. LMR Partners LLP purchased a new stake in Acadia Healthcare during the 3rd quarter worth about $1,616,000. Finally, Sivik Global Healthcare LLC boosted its position in shares of Acadia Healthcare by 43.7% during the 3rd quarter. Sivik Global Healthcare LLC now owns 115,000 shares of the company’s stock worth $7,292,000 after acquiring an additional 34,997 shares in the last quarter.

Acadia Healthcare Stock Down 1.8 %

ACHC stock opened at $41.96 on Friday. Acadia Healthcare Company, Inc. has a one year low of $36.50 and a one year high of $87.77. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The company has a fifty day moving average of $42.10 and a 200-day moving average of $54.83. The stock has a market capitalization of $3.90 billion, a PE ratio of 13.76, a price-to-earnings-growth ratio of 1.75 and a beta of 1.30.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the company. TD Cowen decreased their target price on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a research note on Tuesday, January 7th. StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, January 6th. Barclays reduced their price target on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research report on Friday, November 22nd. Cantor Fitzgerald reiterated a “neutral” rating and set a $52.00 target price on shares of Acadia Healthcare in a research report on Tuesday, December 10th. Finally, Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their price target for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. One analyst has rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, Acadia Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $70.22.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.